Differential effects of esculetin and daphnetin on in vitro cell proliferation and in vivo estrogenicity

European Journal of Pharmacology

Volumn 668, Issue 1-2, 2011, Pages 35-41

  Jiménez Orozco, Fausto Alejandro ^a   Rosales, Ana Alejandra Román ^b   Vega López, Armando ^c   Domínguez López, Maria Lilia ^c   García Mondragón, Ma Juana ^a   Maldonado Espinoza, Amelia ^a   Lemini, Cristina ^a   Mendoza Patiño, Nicandro ^a   Mandoki, Juan José ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Antiproliferative effect; Coumarin; Cyclin D1; Daphnetin; Esculetin; Estrogenicity

Indexed keywords

CYCLIN D1; DAPHNETIN; ESCULETIN; ESTRADIOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; ESTROGEN ACTIVITY; FEMALE; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; UTERUS WEIGHT;

ANIMALS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; ESTROGENS; FEMALE; FLOW CYTOMETRY; HUMANS; MICE; ORGAN SIZE; UMBELLIFERONES; UTERUS;

EID: 80052072002     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.06.024     Document Type: Article

References (42)

1. C.Y. Chu, Y.Y. Tsai, C.J. Wang, W.L. Lin, and T.H. Tseng Induction of apoptosis by esculetin in human leukemia cells Eur. J. Pharmacol. 416 2001 25 32
2. D. Egan, R. O'Kennedy, E. Moran, D. Cox, E. Prosser, and R.D. Thornes The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds Drug Metab. Rev 22 1990 503 529
3. S.V. Fernández, and J. Russo Estrogen and xenoestrogens in breast cancer Toxicol. Pathol. 38 2010 110 122
4. G.J. Finn, B. Creaven, and D.A. Egan Study of the in vitro cytotoxic potential of natural and synthetic coumarin derivatives using normal and neoplastic human skin cell lines Melanoma Res. 11 2001 446 467
5. G.J. Finn, E. Kenealy, B.S. Creaven, and D.A. Egan In vitro cytotoxic potential and mechanism of action of selected coumarins, using human renal cell lines Cancer Lett. 183 2002 61 68 (Pubitemid 34607352)
6. G.J. Finn, B.S. Creaven, and D.A. Egan Daphnetin induced differentiation of human renal carcinoma cells and its mediation by p38 mitogen-activated protein kinase Biochem. Pharmacol. 67 2004 1779 1788 (Pubitemid 38479856)
7. K.C. Fylaktakidou, D.J. Hadjipavlou-Litina, K.E. Litinas, and D.N. Nicolaides Natural and synthetic coumarin derivatives with anti-inflammatory/ antioxidant activities Curr. Pharm. Des. 10 2004 3813 3833 (Pubitemid 39409872)
8. W.G. Helferich, J.E. Andrade, and M.S. Hoagland Phytoestrogens and breast cancer: a complex story Inflammopharmacology 16 2008 219 226
9. J. Hofmanova, K. Soucek, J. Pacherník, M. Kovaríková , Z. Hoferová, K. Minksová, J. Netíková, and A. Kozubík Lipoxygenase inhibitors induce arrest of tumour cells in S-phase of the cell cycle Neoplasma 49 2002 362 367 (Pubitemid 36139236)
10. C.J. Hsieh, R.C. Santell, S.Z. Haslam, and W.G. Helferich Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo Cancer Res. 58 1998 3833 3838 (Pubitemid 28405638)
11. F.A. Jiménez-Orozco, J.A. Molina-Guarneros, N. Mendoza-Patiño, B. Flores-Pérez, F. León-Cedeño, E. Santos-Santos, and J.J. Mandoki Cytostatic activity of coumarin metabolites and derivatives in the B16 F10 murine melanoma cell line Melanoma Res. 9 1999 243 247 (Pubitemid 29461141)
12. F.A. Jiménez-Orozco, J.S. Lopez, A. Nieto, J. Molina, M.A. Velasco, N. Mendoza, M.J. García, P. Elizalde, F. León, and J.J. Mandoki Decrease of cyclin D1 in the human lung adenocarcinoma cell line A-427 by 7-hydroxycoumarin Lung Cancer 34 2001 185 194 (Pubitemid 33010794)
13. S. Kawaii, Y. Tomono, K. Ogawa, M. Sugiura, M. Yano, and Y. Yoshizawa The antiproliferative effect of coumarins on several cancer cell lines Anticancer. Res. 21 2001 917 924 (Pubitemid 32494190)
14. M. Kawase, H. Sakagami, K. Hashimoto, S. Tani, H. Hauer, and S.S. Chatterjee Structure-cytotoxic activity relationships of simple hydroxylated coumarins Anticancer. Res. 23 2003 3243 3246 (Pubitemid 36975419)
15. J.K. Kim, and J.A. Diehl Nuclear cyclin D1: an oncogenic driver in human cancer J. Cell. Physiol. 220 2009 292 296
16. C.J. Kirk, R.M. Harris, D.M. Wood, R.H. Waring, and P.J. Hughes Do dietary phytoestrogens influence susceptibility to hormone-dependent cancer by disrupting the metabolism of endogenous oestrogens? Biochem. Soc. Trans. 29 Pt 2 2001 209 216 (Pubitemid 32587507)
17. S. Kirkiacharian, H. Chidiack, D. Philibert, Van De Velde P., and F. Bouchoux Binding affinity to steroid hormone receptors and antiproliferative action on MCF-7 cells of coumarin derivatives and isoflavonoids Ann. Pharm. Fr. 57 1999 332 339 (Pubitemid 29376323)
18. H. Kolodziej, O. Kayser, H.J. Woerdenbag, W. van Uden, and N. Pras Structure-cytotoxicity relationships of a series of natural and semi-synthetic simple coumarins as assessed in two human tumour cell lines Z. Naturforsch. C. 52 1997 240 244 (Pubitemid 27195359)
19. A. Lacy, and R. O'Kennedy Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer Curr. Pharma. Des 10 2004 3797 3811 (Pubitemid 39409871)
20. S.H. Lee, C. Park, C.Y. Jin, G.Y. Kim, S.K. Moon, J.W. Hyun, W.H. Lee, B.T. Choi, T.K. Kwon, Y.H. Yoo, and Y.H. Choi Involvement of extracellular signal-related kinase signaling in esculetin induced G1 arrest of human leukemia U937 cells Biomed. Pharmacother. 62 2008 723 729
21. C. Lemini, R. Jaimez, M.E. Ávila, Y. Franco, F. Larrea, and A.E. Lemus In vivo and in vitro estrogen bioactivities of alkyl parabens Toxicol. Ind. Health 19 2003 69 79 (Pubitemid 40036696)
22. J.S. Lewis, V. Vijayanathan, T.J. Thomas, R.G. Pestell, Ch. Albanese, M.A. Gallo, and T. Thomas Activation of cyclin D1 by estradiol and spermine in MCF-7 breast cancer cells: a mechanism involving the p38 MAP kinase and phosphorylation of ATF-2 Oncol. Res. 15 2005 113 128 (Pubitemid 40978709)
23. S.C. Liang, G.B. Ge, H.X. Liu, Y.Y. Zhang, L.M. Wang, J.W. Zhang, L. Yin, W. Li, Z.Z. Fang, J.J. Wu, G.H. Li, and L. Yang Identification and characterization of human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of daphnetin Drug Metab. Dispos. 38 2010 973 980
24. J.S. Lopez-Gonzalez, H. Prado-Garcia, D. Aguilar-Cazares, J.A. Molina-Guarneros, J. Morales-Fuentes, and J.J. Mandoki Apoptosis and cell cycle disturbances induced by coumarin and 7-hydroxycoumarin on human lung carcinoma cell lines Lung Cancer 43 2004 275 283 (Pubitemid 38224147)
25. M.E. Marshall, K. Butler, and A. Fried Phase I evaluation of coumarin (1,2-benzopyrone) and cimetidine in patients with advanced malignancies Mol. Biother. 3 1991 170 178
26. J.A. McKie, S.S. Bhagwat, H. Brady, M. Doubleday, L. Gayo, M. Hickman, R.K. Jalluri, S. Khammungkhune, A. Kois, D. Mortensen, N. Richard, J. Sapienza, G. Shevlin, B. Stein, and M. Sutherland Lead identification of a potent benzopyranone selective estrogen receptor modulator Bioorg. Med. Chem. Lett. 14 2004 3407-1310
27. J.L. Mohler, L.G. Gomella, E.D. Crawford, L.M. Glode, C.D. Zippe, W.R. Fair, and M.E. Marshall Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic carcinoma Prostate 20 1992 123 131
28. M.A. Musa, J.S. Cooperwood, and M.O. Khan A review of coumarin derivatives in pharmacotherapy for breast cancer Curr. Med. Chem. 15 2008 2664 2679
29. S.L. Pan, Y.W. Huang, J.H. Guh, Y.L. Chang, C.Y. Peng, and C.M. Teng Esculetin inhibits Ras-mediated cell proliferation and attenuates vascular restenosis following angioplasty in rats Biochem. Pharmacol. 65 2003 1897 1905
30. H.B. Patisaul, and W. Jefferson The pros and cons of phytoestrogens Front. Neuroendocrinol. 31 2010 400 419
31. W.J. Petty, K.H. Dragnev, and E. Dmitrovsky Cyclin D1 as a target for chemoprevention Lung Cancer 41 2003 155 161
32. M.E. Riveiro, N. De Kimpe, A. Moglioni, R. Vázquez, F. Monczor, C. Shayo, and C. Davio Coumarins: old compounds with novel, promising therapeutic perspectives Curr. Med. Chem. 17 2010 1325 1338
33. A.M. Soto, H. Justicia, J.W. Wray, and C. Sonnenschein p-Nonylphenol: an estrogenic xenobiotic released from "modified" polystyrene Environ. Health Perspect. 92 1991 167 173
34. A.M. Soto, C. Sonnenschein, K.L. Chung, M.F. Fernandez, N. Olea, and F. Olea The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants Environ. Health Perspect. 103 1995 113 122
35. C.K. Taylor, R.M. Levy, J.C. Elliott, and B.P. Burnett The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies Nutr. Rev. 67 2009 398 415
36. R.D. Thornes, L. Daly, G. Lynch, B. Breslin, H. Browne, H.Y. Browne, T. Corrigan, P. Daly, G. Edwards, E. Gaffney, J. Henley, T. Henley, F. Keana, F. Lennon, N. McMurray, S. O'Loughlin, M. Shine, and A. Tanner Treatment with coumarin to prevent or delay recurrence of malignant melanoma J. Cancer Res. Clin. Oncol. 120 1994 32 34
37. T. Usui Pharmaceutical prospects of phytoestrogens Endocr. J. 53 2006 7 20
38. M.A. Velasco-Velázquez, Z. Li, M. Casimiro, E. Loro, N. Homsi, and R.G. Pestell Examining the role of cyclin D1 in breast cancer Future Oncol. 6 2011 753 765
39. C.J. Wang, Y.J. Hsieh, C.Y. Chu, Y.L. Lin, and T.H. Tseng Inhibition of cell cycle progression in human leukemia HL-60 cells by esculetin Cancer Lett. 183 2002 163 168
40. I.I. Witzel, L.F. Koh, D. Neil, and N.D. Perkins Regulation of cyclin D1 gene expression Biochem. Soc. Trans. 38 2010 217 222
41. E.B. Yang, Y.N. Zhao, K. Zhang, and P. Mack Daphnetin, one of coumarin derivatives, is a protein kinase inhibitor Biochem. Biophys. Res. Commun. 260 1999 682 685 (Pubitemid 29371111)
42. J.H. Zar Biostatistical analysis B.N.J. Kurts, Multiple Comparisons second ed. 1984 Prentice-Hall Englewood Cliffs. NJ 194 195